Study to evaluate the effectiveness of Nilotpaladi churna in treating asrugdar(excessive menstrual bleeding) with a focus on menorrhagia
- Conditions
- Excessive and frequent menstruation with regular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH, (2) ICD-10 Condition: N920||Excessive and frequent menstruation with regular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH, (3) ICD-10 Condition: N920||Excessive and frequent menstruation with regular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,
- Registration Number
- CTRI/2025/06/089054
- Lead Sponsor
- Dr. Gavale Shital Tanaji
- Brief Summary
Title
Randomized controlled clinical trial to evaluate the efficacy of Nilopaladi churna in the management of asrugdar with special referance to menorrhagia
Objective
To evaluate the efficacy of Nilotapaladi churna in the management of asrugdar with special reference to menorrhagia.
To define asrugdar in term of heavy menstrual bleeding.
To review the details of asrugdar in ayurveda literature.
Open simple randomized clinical study ,initial assesment and selection of patients
60 randomized selected patients of asrugdar will be divided in to two groups (trial group A and control group B)
Each group contains 30 patients. Informed written consent will be taken from each patients prior to research
Authentication and standardization of trial drug and control drug Nilotpadali churna will be done
Group A Group B
(Trial Group) (Control Group)
4gm Nilotapaladi churna TDS 4gm Nilotapaladi churna TDS
for 3 cosecutive menstrual cycle in for 3 consecutive menstrual cycle in
apankal with anupan honey apankal with anupan tandulodak or honey
Observation will be done up to 3 consequent menstrual cycle starting from 1st menstrual cycle of treatment
To trial group A Nilotapaladi churna will be give for 3 months
To control group B Pushyanug churna will be give for 3 months
All observed changes will be recorded
Follow up on 1st, 3rd, 5th day of menstrual cycle for 3 cycle
obsevation ,
Discussion,
Conclusion ,
Summary
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 60
- Age 18-45 year women Patients with excessive vaginal bleeding more than 4 days without having any pathogenesis Patient with per vaginal bleeding before & after Menses without having any pelvic organ pathogenesis Quantity of Menstrual blood must be greater than 80-100 ml/menstrual cycle Patient with absolute symptoms of Asrugdar like 1 Atyadhik raktastrav 2 Anrutukal raktastrav 3 katishool 4 Adhodarshool 5 Sarvangmard Patients having sign and symptoms of menorrhagia like Excessive vaginal bleeding Long duration of blood flow during menses Passage of deep clots Patient having any one of symptoms with or without bodyache, weakness, giddiness, anemia,etc.
- Voluntary willing patients Patients irrespective of religion,cast,pathy,occupation Hb% 8 to more than 8gm%.
Patients having cervical, uterine polyp Patients having genital malignancy Patients suffering from HIV,STD, Hepatitis B Patients suffering from disorder like genital TB Patients with chronic illness Utwrine fibroid and other pelvic pathologies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the efficacy of Nilotpladi churna orally in the management of Asrugdar with special referance to menorrhagia 5 days
- Secondary Outcome Measures
Name Time Method 1)To study the efficacy of Nilotpladi churna orally in the management of Asrugdar with special reference to menorrhagia 2)To compaire the Nilotpladi churna orally with Pushyanug churna orally in the management of Asrugdar with special referance to menorrhagia
Trial Locations
- Locations (1)
Late Kedari Redekar Ayurvedic Hospital And Research Centre
🇮🇳Kolhapur, MAHARASHTRA, India
Late Kedari Redekar Ayurvedic Hospital And Research Centre🇮🇳Kolhapur, MAHARASHTRA, IndiaDrShital Tanaji GavalePrincipal investigator9284945638shitalgavale1999@gmail.com